News | January 06, 2022
Margins under pressure; domestic market growth to slow down: Nirmal Bang
A preview on Q3FY22 by Nirmal Bang Securities on select Indian pharma companies
A preview on Q3FY22 by Nirmal Bang Securities on select Indian pharma companies
BPZE1 is the most advanced next-generation pertussis vaccine currently in clinical development
The combination enhances Comar's customer value proposition by adding complementary closure and jar products and related precision mold-making expertise
The facility at the Andhra Pradesh Medtech Zone is expected to be completed by Dec 2022
DCGI approved the drug based on the review of clinical data
The single-dose vaccine has been approved in China, Mexico, Ecuador, Chile, Argentina, Hungary, Kirghizstan, Pakistan, Indonesia and Malaysia
SAGE recommends additional third dose of the vaccine administered to immunocompromised persons
The company has started manufacturing the Sputnik Light vaccine
Trastuzumab is monoclonal antibody used to treat human epidermal growth factor receptor 2 positive (HER2+) breast cancer and metastatic gastric cancers
TeleRay partners with Radiobotics, adding Artificial Intelligence to their pre-existing integrated best-in-class medical image and patient information distribution platform
Subscribe To Our Newsletter & Stay Updated
